Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control

Practical Radiation Oncology

Volumn 2, Issue 4, 2012, Pages 288-295

  Mehta, Niraj ^a   King, Christopher R ^a   Agazaryan, Nzhde ^a   Steinberg, Michael ^a   Hua, Amanda ^a   Lee, Percy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOLOGICAL EFFECTIVE DOSE; CANCER CONTROL; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STATISTICAL MODEL; STEREOTACTIC BODY RADIATION THERAPY; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY;

EID: 84866518334     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2011.10.004     Document Type: Article

References (57)

1. Finlayson E, Fan Z, Birkmeyer JD Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg 2007, 205:729-734.
2. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
3. Dominioni L, Imperatori A, Rovera F, Ochetti A, Torrigiotti G, Paolucci M Stage I nonsmall cell lung carcinoma: Analysis of survival and implications for screening. Cancer 2000, 89(11 Suppl):2334-2344.
4. Cykert S, Dilworth-Anderson P, Monroe MH, et al. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 2010, 303:2368-2376.
5. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
6. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003, 41:1-11.
7. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in nonsmall-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 2001, 19:127-136.
8. Adebonojo SA, Bowser AN, Moritz DM, Corcoran PC Impact of revised stage classification of lung cancer on survival: A military experience. Chest 1999, 115:1507-1513.
9. Fowler JF, Tomé WA, Fenwick JD, Mehta MP A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004, 60:1241-1256.
10. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R Systemic review of the patterns of failure following stereotactic body radiation therapy in earlystage non-small-cell lung cancer: Clinical implications. Radiother Oncol 2010, 94:1-11.
11. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
12. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005, 63:1010-1015.
13. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101:1623-1631.
14. Fowler JF, Tome WA, Welsh JS On the estimation of required doses in stereotactic body radiation therapy. Stereotactic Body Radiation Therapy 2005, 99-107. Williams & Wilkins, Philadelphia, PA. B.D. Kavanagh, R.D. Timmerman (Eds.).
15. Park C, Papiez L, Zhang S, Story M, Timmerman RD Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:847-852.
16. National Cancer Institute. ClinicalTrials.gov: National Lung Screening Trial (NLST), Identifier NCT00047385. Available at: 2010, 2002. Accessed August 19, 2011. http://clinicaltrials.gov/ct/show/NCT00047385.
17. Fritz P, Kraus HJ, Blaschke T, et al. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four dimensional CT scans for treatment planning. Lung Cancer 2008, 60:193-199.
18. Pennathur A, Luketich JD, Heron DE, et al. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2009, 137:597-604.
19. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
20. Takeda A, Sanuki N, Kunieda E, et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys 2009, 73:442-448.
21. Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45:787-795.
22. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial. Lung Cancer 2010, 68:72-77.
23. Kopek N, Paludan M, Petersen J, et al. Stereotactic body radiotherapy for medically inoperable stage I non-small cell lung cancer: Mature outcome and toxicity results. Int J Radiat Oncol Biol Phys 2008, 72(Suppl):S37.
24. Koto M, Takai Y, Ogawa Y, et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2007, 85:429-434.
25. Onimaru R, Fujino M, Yamazaki K, et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:374-381.
26. Salazar OM, Sandhu TS, Lattin PB, et al. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early stage, 42 locally advanced, and 7 metastatic lung cancers. Int J Radiat Oncol Biol Phys 2008, 72:707-715.
27. Chang JY, Balter PA, Dong L, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 72:967-971.
28. Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 2007, 110:148-155.
29. Hoyer M Prospective Study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66(4 Suppl):S128-S135.
30. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
31. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006, 1:802-809.
32. Ng AW, Tung SY, Wong VY Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer-report on clinical outcome and dose to critical organs. Radiother Oncol 2008, 87:24-28.
33. Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66:117-125.
34. Yoon SM, Choi EK, Lee SW, et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 2006, 45:1108-1114.
35. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 2006, 45:796-801.
36. van der Voort van Zyp NC, Prevost JB, Hoogeman MS, et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: Clinical outcome. Radiother Oncol 2009, 91:296-300.
37. Song SY, Choi W, Shin SS, et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 2009, 66:89-93.
38. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
39. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S Stage I nonsmall cell lung cancer in patients aged > or = 75 years: Outcomes after stereotactic radiotherapy. Cancer 2010, 116:406-414.
40. Pennathur A, Luketich JD, Burton S, et al. Stereotactic radiosurgery for the treatment of lung neoplasm: Initial experience. Ann Thorac Surg 2007, 83:1820-1825.
41. Guckenberger M, Wulf J, Mueller G, et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: Relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009, 74:47-54.
42. Hayakawa K, Mitsuhashi N, Saito Y, et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 1999, 26:137-142.
43. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993, 27:517-523.
44. Slotman BJ, Antonisse IE, Njo KH Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 1996, 41:41-44.
45. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1997, 38:521-525.
46. Sandler HM, Curran WJ, Turrisi AT The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990, 19:9-13.
47. Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RE Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988, 15:69-73.
48. Noordijk EM, vd Poest Clement E, Hermans J, Wever AM, Leer JW Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 1988, 13:83-89.
49. Morita K, Fuwa N, Suzuki Y, et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients. Radiother Oncol 1997, 42:31-36.
50. Cheung PC, Mackillop WJ, Dixon P, Brundage MD, Youssef YM, Zhou S Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2000, 48:703-710.
51. Cheung PC, Yeung LT, Basrur V, Ung YC, Balogh J, Danjoux CE Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 54:1014-1023.
52. Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer. Radiother Oncol 2008, 87:29-34.
53. Chen Y, Guo W, Lu Y, Zou B Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy. Radiother Oncol 2008, 88:351-358.
54. Narayan S, Henning GT, Ten Haken RK, Sullivan MA, Martel MK, Hayman JA Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004, 44:79-88.
55. Zhao L, Chen M, Ten Haken R, et al. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located. Radiother Oncol 2007, 82:153-159.
56. Krol AD, Aussems P, Noordijk EM, Hermans J, Leer JW Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996, 34:297-302.
57. Sibley GS Radiotherapy for patients with medically inoperable dtage I nonsmall cell lung carcinoma: smaller volumes and higher doses-a review. Cancer 1998, 82:433-438.